Analyte detection assay and methods of use |
| OF THE PREFERRED EMBODIMENTS In a preferred aspect of this invention, the invention relates to a ... |
|
Heterdoyne Thickness Monitoring System |
| A Chemical Mechanical Polishing heterodyne in-situ sensor (C-HIS) apparatus and method for enhanced ... |
|
Solid-state displacement element, optical element, and interference filter |
| Accordingly, it is an object of the present invention to provide a solid-state displacement element ... |
|
Amplification of nucleic acids with electronic detection |
| In accordance with the objects outlined above, the present invention provides methods for detecting ... |
|
Polymer nanocomposites for lithium battery applications |
| An important object of the present invention is to provide an improved electrolyte for a lithium ... |
|
Biocompatible polymer film |
| OF THE INVENTION The present invention includes a co-polymer film which can be applied over a ... |
|
Method of semiconductor manufacture using an inverse self-aligned mask |
| In accordance with the present invention, a novel method for forming an inverse self-aligned mask ... |
|
Silicon quantum dot laser |
| An object of the present invention is to provide apparatus and methods to dynamically vary or ... |
|
|
Parallel SELEX.TM.
| Details |
Inventors: Eaton, Bruce; Tarasow, Theodore M.;
Assignee: NeXstar Pharmaceuticals, Inc. (Boulder, CO)
Primary Examiner: Zitomer; Stephanie W.
Assistant Examiner:
Attorney, Agent or Firm: Swanson & Bratschun, L.L.C.
This invention discloses a method for coevolving products from two or more reactants, along with the nucleic acid that can facilitate the reaction for making the products. The invention further discloses the products and facilitating nucleic acids produced by said method. |
|
DETAILED DESCRIPTION OF THE INVENTION The Parallel SELEX. TM. process provides product libraries which are formed by combining a pool of first chemical reactants coupled to a nucleic acid with a pool of free chemical reactants. The coupled nucleic acid is capable of mediating the chemical reaction which leads to the product library and further the nucleic acid is amplifiable so a product which has a predetermined desirable characteristic can be enriched for and identified from the product library. In its most general form, the Parallel SELEX. TM. process may be described as in FIG. 1. A nucleic acid-reactant test mixture is formed by attaching a first reactant (R) to each of the nucleic acids in a test mixture (containing 10. sup. 2 to 10. sup. 18 nucleic acids with randomized sequences). The nucleic acid-reactant test mixture is treated with other free reactants (denoted as triangle, pentagon and hexagon) that will combine with the first reactant (R) to form different products. It is important to note that from the nucleic acid test mixture (NA), discrete nucleic acid sequences will be associated with facilitating the formation of the different shaped products as denoted by sequence-A, sequence-B and sequence-C in FIG. 1. The products may differ in shape, reactivity or both shape and reactivity. Partitioning of the desirable product shape or reactivity is accomplished by binding to or reaction with a target. Proteins, small molecules, lipids, saccharides, etc. , are all examples of targets (T). After binding to or reacting with the target the non-interacting products, which are attached to sequence-B and sequence-C as depicted in FIG. 1 are separated from sequence-A and discarded. The nucleic acid sequence-A is then amplified by a variety of methods known to those experienced in the art. Sequence-A is then used to facilitate the assembly of the desirable product by facilitating the specific reaction to form the selected product on treatment with the mixture of starting reactants. In a typical reaction, Sequence-A can be reattached to the first reactant, however, said reattachment is not always required
|
| Related patents |
|
|
Method of making a magnetoelectronic device
An object of the present invention therefore is to provide an improved architecture for a hybrid Hall Effect device to be used as a memory cell in a memory array. A ...
|
|
|
Method of manufacturing a semiconductor device having interconnetion patterns
One object of the present invention is to form a very minute interconnection pattern having line width less than that of an interconnection pattern formed using a ...
|
|
|
Photoconductive layer having hydrophilic and hydrophobic moieties
An object of the present invention is to provide a photosensitive member, in particular, an electrophotographic photosensitive member, free from the abovementioned ...
|
|
|
Immunoassay for CK-MB using bound and soluble antibodies
I claim: 1. An immunoinhibition assay for CK-MB comprising the steps of: (a) forming a first reaction mixture by contacting a liquid sample suspected of containing CK-MB ...
|
|
|
Layer of metallomacrocyclic polymer on substrate
We claim: 1. A layer element which comprises a base having a hydrophobic surface and, applied on the said base, one or more solid, thin, ordered layers having a defined ...
|
|
|
Immunoassay device for continuous monitoring
In accordance with the present invention, there is provided a device for detecting the presence of organic molecular analytes in fluid, the device including first ...
|
|
|
Lyophilized ligand-receptor complexes for assays and sensors
Accordingly, it is one object of the present invention to provide novel ligand-receptor complexes which are suitable for use in a displacement assay. It is another ...
|
|
|
Erasable optical memory and method
The present invention seeks to provide a novel optical memory system, and associated fabrication and operating methods, that has a high memory density and data coding ...
|
|
|
Method for the particularly sensitive detection of nucleic acids
We claim: 1. A method of detecting a target nucleic acid A, comprising: a) hybridizing the target nucleic acid A with a probe nucleic acid B comprising (1) a sequence B1 ...
|
|
|
Sensitive immunoassays utilizing antibody conjugates with replicable DNA templates
Aspects of this invention revolve around antibody-variant DNA conjugates that are immunoassay reagents. The conjugates are components of an immunoassay signal ...
|
|
|